Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

BACKGROUND: Valacyclovir has been used for prophylaxis against cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT). We investigated the efficacy and safety of high-dose Valacyclovir as pre-emptive therapy in patients with CMV antigenemia after HSCT. METHODS: In a ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Shin-Yeu, Truong, Ha-Thi-Thu, Diong, Colin Phipps, Linn, Yeh-Ching, Ho, Aloysius Yew-Leng, Goh, Yeow-Tee, Hwang, William Ying-Khee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471913/
https://www.ncbi.nlm.nih.gov/pubmed/26090121
http://dx.doi.org/10.1186/s12878-015-0028-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471913/
https://www.ncbi.nlm.nih.gov/pubmed/26090121
http://dx.doi.org/10.1186/s12878-015-0028-2

Ejemplares similares